Srilaxmi Nerella
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Srilaxmi Nerella has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Edwin J. C. G. van Den Oord
Center for Biomarker Research and Precision Medicine, Virginia Commonwealth University, Richmond, VA, USA
2 shared publications - Karolina A. Aberg
Center for Biomarker Research and Precision Medicine, Virginia Commonwealth University, Richmond, VA, USA
2 shared publications - Christina M. Hultman
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 77 Stockholm, Sweden
1 shared publication - Guimin Gao
Department of Biostatistics, School of Medicine, Virginia Commonwealth University, Richmond, VA, 23298-0032, U.S.A
1 shared publication - Gábor Rudolf
Center for Biomarker Research and Personalized Medicine, School of Pharmacy, Virginia Commonwealth University, 1112 East Clay Street, P.O. Box 980533, Richmond, VA, 23298, USA
1 shared publication - Joseph L. McClay
Virginia Commonwealth University
1 shared publication
Latest Publications
- Open Access
- 2 March 2013
- Published by Springer Nature in BMC Bioinformatics
- Vol. 14 (1) , 74
MethylPCA: a toolkit to control for confounders in methylome-wide association studies
Background: In methylome-wide association studies (MWAS) there are many possible differences between cases and controls (e.g. related to life style, diet, and medication use) that may affect the methylome and produce false positive findings. An effective approach to control for these confounders is to first capture the major sources of variation in the methylation data and then regress out these components in the association analyses. This approach is, however, computationally very challenging due to the extremely large number of methylation sites in the human genome. Result: We introduce MethylPCA that is specifically designed to control for potential confounders in studies where the number of methylation sites is extremely large. MethylPCA offers a complete and flexible data analysis including 1) an adaptive method that performs data reduction prior to PCA by empirically combining methylation data of neighboring sites, 2) an efficient algorithm that performs a principal component analysis (PCA) on the ultra high-dimensional data matrix, and 3) association tests. To accomplish this MethylPCA allows for parallel execution of tasks, uses C++ for CPU and I/O intensive calculations, and stores intermediate results to avoid computing the same statistics multiple times or keeping results in memory. Through simulations and an analysis of a real whole methylome MBD-seq study of 1,500 subjects we show that MethylPCA effectively controls for potential confounders. Conclusions: MethylPCA provides users a convenient tool to perform MWAS. The software effectively handles the challenge in memory and speed to perform tasks that would be impossible to accomplish using existing software when millions of sites are interrogated with the sample sizes required for MWAS.
- 2 March 2013
- Published by Springer Nature in BMC Bioinformatics
- Vol. 14 (1) , 74
Open AccessMethylPCA: a toolkit to control for confounders in methylome-wide association studies
Background: In methylome-wide association studies (MWAS) there are many possible differences between cases and controls (e.g. related to life style, diet, and medication use) that may affect the methylome and produce false positive findings. An effective approach to control for these confounders is to first capture the major sources of variation in the methylation data and then regress out these components in the association analyses. This approach is, however, computationally very challenging due to the extremely large number of methylation sites in the human genome. Result: We introduce MethylPCA that is specifically designed to control for potential confounders in studies where the number of methylation sites is extremely large. MethylPCA offers a complete and flexible data analysis including 1) an adaptive method that performs data reduction prior to PCA by empirically combining methylation data of neighboring sites, 2) an efficient algorithm that performs a principal component analysis (PCA) on the ultra high-dimensional data matrix, and 3) association tests. To accomplish this MethylPCA allows for parallel execution of tasks, uses C++ for CPU and I/O intensive calculations, and stores intermediate results to avoid computing the same statistics multiple times or keeping results in memory. Through simulations and an analysis of a real whole methylome MBD-seq study of 1,500 subjects we show that MethylPCA effectively controls for potential confounders. Conclusions: MethylPCA provides users a convenient tool to perform MWAS. The software effectively handles the challenge in memory and speed to perform tasks that would be impossible to accomplish using existing software when millions of sites are interrogated with the sample sizes required for MWAS.
- Open Access
- 12 February 2013
- Published by Springer Nature in BMC Bioinformatics
- Vol. 14 (1) , 50
Estimation of CpG coverage in whole methylome next-generation sequencing studies
Methylation studies are a promising complement to genetic studies of DNA sequence. However, detailed prior biological knowledge is typically lacking, so methylome-wide association studies (MWAS) will be critical to detect disease relevant sites. A cost-effective approach involves the next-generation sequencing (NGS) of single-end libraries created from samples that are enriched for methylated DNA fragments. A limitation of single-end libraries is that the fragment size distribution is not observed. This hampers several aspects of the data analysis such as the calculation of enrichment measures that are based on the number of fragments covering the CpGs.
- 12 February 2013
- Published by Springer Nature in BMC Bioinformatics
- Vol. 14 (1) , 50
Open AccessEstimation of CpG coverage in whole methylome next-generation sequencing studies
Methylation studies are a promising complement to genetic studies of DNA sequence. However, detailed prior biological knowledge is typically lacking, so methylome-wide association studies (MWAS) will be critical to detect disease relevant sites. A cost-effective approach involves the next-generation sequencing (NGS) of single-end libraries created from samples that are enriched for methylated DNA fragments. A limitation of single-end libraries is that the fragment size distribution is not observed. This hampers several aspects of the data analysis such as the calculation of enrichment measures that are based on the number of fragments covering the CpGs.